PCVX
Vaxcyte Inc
NASDAQ · Biotechnology
$56.15
+2.24 (+4.16%)
Performance
1D
—
1W
-2.18%
1M
+22.49%
3M
+22.97%
6M
+77.97%
1Y
-34.66%
YTD
+20.86%
Open$55.16
Previous Close$53.91
Day High$56.45
Day Low$54.32
52W High$91.02
52W Low$27.66
Volume1.05M
Avg Volume2.10M
Market Cap7.97B
P/E Ratio—
EPS$-4.84
SectorBiotechnology
Volume Analysis
0.50x average volume
Technical Indicators
SMA 50
$48.23
Above
SMA 200
$39.04
Above
RSI (14)
69.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+19.5% upside
Current
$56.15
$56.15
Target
$67.08
$67.08
$56.09
$67.08 avg
$108.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.07B | 3.02B | 2.41B |
| Net Income | 147.42M | 150.65M | 124.53M |
| Profit Margin | 4.8% | 5.0% | 5.2% |
| EBITDA | 264.93M | 279.22M | 238.21M |
| Free Cash Flow | 132.34M | 114.72M | 94.55M |
| Rev Growth | +1.9% | +8.9% | +10.2% |
| Debt/Equity | 1.24 | 1.35 | 1.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |